These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235 [TBL] [Abstract][Full Text] [Related]
6. The role of apoptosis in pulmonary fibrosis. Kuwano K; Hagimoto N; Nakanishi Y Histol Histopathol; 2004 Jul; 19(3):867-81. PubMed ID: 15168350 [TBL] [Abstract][Full Text] [Related]
7. Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways. Blaauboer ME; Emson CL; Verschuren L; van Erk M; Turner SM; Everts V; Hanemaaijer R; Stoop R Matrix Biol; 2013; 32(7-8):424-31. PubMed ID: 23648810 [TBL] [Abstract][Full Text] [Related]
8. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis. Howell DC; Laurent GJ; Chambers RC Biochem Soc Trans; 2002 Apr; 30(2):211-6. PubMed ID: 12023853 [TBL] [Abstract][Full Text] [Related]
9. The Bleomycin Model of Pulmonary Fibrosis. Liu T; De Los Santos FG; Phan SH Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192 [TBL] [Abstract][Full Text] [Related]
10. The role of TGF-beta in pulmonary fibrosis. Khalil N; Greenberg AH Ciba Found Symp; 1991; 157():194-207; discussion 207-11. PubMed ID: 1712697 [TBL] [Abstract][Full Text] [Related]
11. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis. De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157 [TBL] [Abstract][Full Text] [Related]
12. Association analysis reveals genetic variation altering bleomycin-induced pulmonary fibrosis in mice. Paun A; Lemay AM; Tomko TG; Haston CK Am J Respir Cell Mol Biol; 2013 Mar; 48(3):330-6. PubMed ID: 23239499 [TBL] [Abstract][Full Text] [Related]
13. Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis. Addis-Lieser E; Köhl J; Chiaramonte MG J Immunol; 2005 Aug; 175(3):1894-902. PubMed ID: 16034133 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of MEN1 gene in radiation-induced pulmonary fibrosis in mice. Wei W; Zhang HY; Gong XK; Dong Z; Chen ZY; Wang R; Yi JX; Shen YN; Jin SZ Gene; 2018 Dec; 678():252-260. PubMed ID: 30099020 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms and mediators of pulmonary fibrosis. Keane MP; Strieter RM; Belperio JA Crit Rev Immunol; 2005; 25(6):429-63. PubMed ID: 16390322 [TBL] [Abstract][Full Text] [Related]
16. Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis. Grabarz F; Aguiar CF; Correa-Costa M; Braga TT; Hyane MI; Andrade-Oliveira V; Landgraf MA; Câmara NOS Inflammopharmacology; 2018 Apr; 26(2):491-504. PubMed ID: 28779430 [TBL] [Abstract][Full Text] [Related]
17. Use of transgenic mouse models to understand the origins of familial pulmonary fibrosis. Glasser SW; Senft AP Curr Pharm Biotechnol; 2011 Sep; 12(9):1447-54. PubMed ID: 21401520 [TBL] [Abstract][Full Text] [Related]
18. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
19. Distribution of HLA antigens in idiopathic pulmonary fibrosis. Fulmer JD; Sposovska MS; von Gal ER; Crystal RG; Mittal KK Am Rev Respir Dis; 1978 Jul; 118(1):141-7. PubMed ID: 677553 [TBL] [Abstract][Full Text] [Related]